Behavioral: Time Restricted Olive Oil Based (TROO) Ketogenic Diet ( DrugBank: Olive oil, Olive )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 13 | Multiple sclerosis/Neuromyelitis optica | 1 |
13. Multiple sclerosis/Neuromyelitis optica
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05007483 (ClinicalTrials.gov) | March 1, 2022 | 9/8/2021 | Efficacy of Diet on Quality of Life in Multiple Sclerosis | Efficacy of Diet on Quality of Life in Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Dietary Supplement: BodyBio Balance Oil;Dietary Supplement: Kirunal Fish Oil;Dietary Supplement: BodyBio PC;Behavioral: Modified Paleolithic Elimination diet;Behavioral: Time Restricted Olive Oil Based (TROO) Ketogenic Diet;Behavioral: Dietary Guidelines for Americans Diet | Terry L. Wahls | NULL | Not yet recruiting | 18 Years | 70 Years | All | 156 | N/A | United States |